Evidence map›Paper›PMID 19950420›Full record

ArticleImmunology2009

Plasma cell toll-like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production.

Marcus Dorner, Simone Brandt, Marianne Tinguely, Franziska Zucol, Jean-Pierre Bourquin, Ludwig Zauner, Christoph Berger, Michele Bernasconi, Roberto F Speck, David Nadal

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 106 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Toll-like Receptors and Thrombopoiesis.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Marcus DornerDivision of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Zurich, Zurich, Switzerland.
Simone Brandt
Marianne Tinguely
Franziska Zucol
Jean-Pierre Bourquin
Ludwig Zauner
Christoph Berger
Michele Bernasconi
Roberto F Speck
David Nadal
University Hospital of Zurich · CHBoston Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptors (TLRs) are key receptors of the innate immune system and show cell subset-specific expression. We investigated the messenger RNA (mRNA) expression of TLR genes in human haematopoietic stem cells (HSC), in naïve B cells, in memory B cells, in plasma cells from palatine tonsils and in plasma cells from peripheral blood. HSC and plasma cells showed unrestricted expression of TLR1-TLR9, in contrast to B cells which lacked TLR3, TLR4 and TLR8 but expressed mRNA of all other TLRs. We demonstrated, for the first time, that TLR triggering of terminally differentiated plasma cells augments immunoglobulin production. Thus, boosting the immediate antibody response by plasma cells upon pathogen recognition may point to a novel role of TLRs.

Indexed as

B-LymphocytesCell DifferentiationCells, CulturedGene Expression RegulationHematopoietic Stem CellsHumansImmunoglobulin GImmunoglobulin MImmunoglobulinsImmunologic MemoryPlasma CellsRNA, MessengerToll-Like ReceptorsImmunoglobulin GImmunoglobulin MImmunoglobulinsRNA, MessengerToll-Like Receptors

Identifiers

PMID19950420
PMCPMC2792141
OpenAlexW1976853865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.